1. Meeting Agenda for 3/28/19
1) Check-in – Positive Focus
2) Framework for the group and founding companies
3) Clearly define end-to-end solution we are aiming to provide
4) Identify key partners to include in the group: providers, payers, foundations, etc.
5) Strategic Plan – start defining the plan.
6) Next steps:
Identify collaboration environment (Sharepoint, Asana)
Create website for OCWG
Work on Strategic Plan
SUH style Worksheets for OCWG
Identify initial pilot (Provider + Payer)

2. Opioid Crisis Working Group
A Startup Health tactical group working together to tackle the opioid crisis.

3. About the Opioid Crisis Working Group
What we do
Housed at Startup Health, the Opioid Crisis Working Group aims to create end-to-end solutions for the opioid crisis through the OCWG strategic plan, which includes:
Prevention and Treatment enhancements
Use of medication-assisted treatment (MAT)
Aftercare solutions which include pain management alternatives.
Structure
The OCWG structure includes its member partners – WellBrain, inRecovery, Sen-Jam, Personal Remedies, Cloud9, Hey, Charlie! - as well as several support teams and committees. Its internal team receives input from Providers, Payers, Government agencies and community-based organizations to help understand the problem and identify solutions.

4. About the Opioid Crisis Working Group
Goal
Create end-to-end solutions for the opioid crisis
Vision
Long term vision / Moonshot statement for OCWG

5. The Framework
Criteria for membership
Time commitments
Quantify the results we’re looking for
Action oriented goals
Timeframe we’re aiming for
Being able to show actual progress and traction
Plan for implementing a strategy.
Traction Plan

6. End-to-End solution
Define End-to-End Solution
Who are we targeting: VA, hospital systems, etc.
Commonalities
What does it mean?
API’s between all companies
Actual integrations?

7. Key Partners
Who do we want to have as part of this group
Criteria / Goals to have context
Worksheet for qualifying partners.
Stakeholders
Providers: Caron, UHS (Nicki Tessler)
Payers: Guidewell (Innovation labs), Anthem
Government: CMS, Medicare / Medicaid, Meridian (in charge of Codes)
Community: Foundations
Gradually add as we identify capabilities we need to meet our goal.

8. Companies

9. Identify your Continuum of Care
Description of the Company:
A SaaS based B2B2C chronic pain digital health platform enabling providers and hospital systems to effectively prescribe evidence based non-opiate modalities to treat chronic pain, save lives, and fight the opiate epidemic.
Product or Service you Provide: an Ipad and smartphone solution using mindfulness and other services on a subscription basis to providers. Patient use is free.
Substance abuse need being addressed by your product or service: opiate usage.
inRecovery
In-patient Out-patient
Pre-Exposure
Exposure
Addiction
Withdrawal
Overdose
Relapse
Identify your Continuum of Care
Who are your Clients: pain providers, neurologists, oncologists, orthopedics, family practice, and other types of practitioners, hospitals, pharma, medical device companies
Who purchases your products or services: same as above and also PATIENTS (free for them)
Who pays for your products or services: right now providers and medical device companies.
What is your biggest barrier to entry: shifting landscape of medical coding – so that physicians and systems feel more comfortable in offering our service.

10. Identify your Continuum of Care
Description of the Company: Focused on Non-Opioid Inflammatory Pain Prevention by repurposing small molecules and using the expedited 505(b)2 pathway to bring drugs to market in less than 3 years. Our goal is to partner with a Licensee for commercialization.
Product or Service you Provide: Pharmaceutical Products
Substance abuse need being addressed by your product or service: Reducing Opioid Withdrawal Symptoms, Tolerance, and Dependence.
inRecovery
In-patient Out-patient
Pre-Exposure
Exposure
Addiction
Withdrawal
Overdose
Relapse
Identify your Continuum of Care
Who are your Clients: Individual persons taking an opioid, Physicians caring for patients taking opioids, Hospitals caring for patients taking opioids, Payors (insurance/PBM) of patients taking opioids.
Who purchases your products or services: Individuals, Hospitals, PBM’s, and In-Recovery/in-patients.
Who pays for your products or services: Individuals, PBM’s, Insurance companies who pay for hospitalization or in-patient care.
What is your biggest barrier to entry: FDA

11. Identify your Continuum of Care
Description of the Company: Substance Use Disorder patients often develop nutrient deficiencies and are at risk with various chronic illnesses. Majority of these health issues can be prevented and treated through dietary and lifestyle changes. Personal Remedies provides fully automated individualized guidance to SUD patients.
Product or Service you Provide: Mobile apps, and an open API to an AI-powered expert system.
Substance abuse need being addressed by your product or service: Provide dietary guidance to patients recovering from SUD and/or at risk with likely nutrient deficiencies and comorbidities.
inRecovery
In-patient Out-patient
Pre-Exposure
Exposure
Addiction
Withdrawal
Overdose
Relapse
Identify your Continuum of Care
Who are your Clients: Providers, Wellness/Health IT vendors, and consumers
Who purchases your products or services: Same as above/our clients.
Who pays for your products or services: Same as above/our clients.
What is your biggest barrier to entry: Buyer reluctance to trust AI/technology, and buyer preference to treat and use conventional medicine to do so.